Borya Pharmaceutical has decided not to redeem the "Borya Convertible Bonds" early, and also will not exercise it in the next three months.

Boya Biomedical Pharmaceutical Co., Ltd. announcement, from August 22, 2025 to September 11, the company's stock has met the condition for conditional redemption, with the closing price for 15 trading days not lower than 130% of the current conversion price for 30 consecutive trading days. On September 11, the company held a board meeting and approved the proposal not to redeem "Boya Convertible Bonds" in advance. Taking into account factors such as the company's operations, stock price, and the market, in order to protect the interests of investors, the company will not exercise its right to early redemption this time, and will not do so even if triggered again in the next three months. In addition, within six months before the redemption condition is met, relevant parties have not traded "Boya Convertible Bonds". The company reminds investors to pay attention to follow-up announcements and investment risks.